Sirona Medical
Sirona Medical Raises $40M Series D for AI-Native Radiology Workflow Software
Sirona Medical announced $40M in Series D financing on October 15, 2026. Sirona Medical announced a $40 million Series D financing led by Avidity Partners, with participation from 8VC, GreatPoint Ventures, KLT Holdings and other investors.
Round details
The financing includes backing from Avidity Partners, 8VC, GreatPoint Ventures, KLT Holdings. The company did not publish a valuation with the announcement.
- Round: Series D
- Capital announced: $40M
How the company plans to use the capital
In the Use of Proceeds section of its announcement, Sirona said the round funds its operating plan indefinitely. It also listed new offices in Burlington, Vermont, and Cincinnati, Ohio, commercialization of Cortex, its agentic AI orchestration layer, and the launch of Sirona Global, its international program, before the end of 2026.
Why this matters for GTM teams
In the announcement, Sirona’s chief executive said the industry is confronting a radiology staffing crisis. The company describes its software as cloud-native and plans to launch an international program, Sirona Global, before the end of 2026.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Sirona Medical Series D announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


